Great Basin Scientific, Inc. (NASDAQ: GBSN), a molecular diagnostics company, announced today that co-founder and Chief Executive Officer, Ryan Ashton, will speak at the 28th Annual ROTH Conference on March 14 at 5PM PDT. Mr. Ashton and Jeff Rona, Great Basin’s Chief Financial Officer, will also be available for one-on-one and group meetings with conference participants on March 14 and 15. To schedule a meeting, please contact email@example.com. More information can be found on the ROTH Capital Partners website at www.roth.com
The Company’s presentation will be available via webcast on the Investors Relations section of the Company website at www.gbscience.com beginning 15 minutes before the presentation time and will be archived for 90 days.
About Great Basin Scientific
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. More information can be found on the company’s website at www.gbscience.com.